Skip to main content

Noninflammatory Degenerative Joint Disease

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
2 programs
Metal on Polyethylene articulationN/A1 trial
Posterior Lateral Approach Total Hip ArthroplastyN/A1 trial
Active Trials
NCT02036931Completed162Est. May 2025
NCT02220478Terminated24Est. Jul 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Zimmer BiometPosterior Lateral Approach Total Hip Arthroplasty
Zimmer BiometMetal on Polyethylene articulation

Clinical Trials (2)

Total enrollment: 186 patients across 2 trials

NCT02220478Zimmer BiometPosterior Lateral Approach Total Hip Arthroplasty

Signature Acetabular Posterior/Lateral Data Collection

Start: Nov 2014Est. completion: Jul 201624 patients
N/ATerminated
NCT02036931Zimmer BiometMetal on Polyethylene articulation

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

Start: Mar 2013Est. completion: May 2025162 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.